Population | Adult and pediatric patients | |
Intervention | Any surveillance or infection control testing or asymptomatic screening conducted for evaluation of the following organisms:
|
Diagnostic testing outside of outbreak surveillance testing Multicomponent intervention studies that did not evaluate the specific contribution of surveillance to downstream colonization or infection results Testing stewardship interventions No microbial organism of interest evaluated Pre-clinical interventions
|
Comparator | Usual practice or other type of PSP |
|
Outcome |
Safety
Quality of care measures
Utilization of healthcare services (focusing on the main utilization measure reported in the study)
Implementation
Barriers and facilitators Resources (cost, staff, time)
|
|
Timing | Original studies published since 2019 | Published before 2019 |
Setting | Inpatient and emergency department settings, nursing, and rehabilitation facilities | Ambulatory, community, or other outpatient settings |
Type of studies | Original studies (Randomized controlled trials or observational studies with a comparison group, including pre-post studies), systematic reviews published since 2019, the year of the search done for the MHS III report on this topic | Guidelines, narrative reviews, scoping reviews, editorials, commentaries, and abstracts |